Conference Coverage

Diabetes Diagnosed at Acute MI Hits Women Harder

Publish date: October 3, 2012

 

AT THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES

The SWEETHEART registry is funded by Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Sanofi, and Novartis. Dr. Tschoepe Tschoepe has received consultancy and speaker remuneration from Astra Zeneca, Bristol-Myers, Squibb, Servier, Sanofi, and Novartis.

Pages

Recommended Reading

FDA Approves First Subcutaneous ICD
MDedge Internal Medicine
Gastric Bypass Benefits Persist at 6 Years' Follow-Up
MDedge Internal Medicine
FDA Reviewing Possible Heart Failure Risk with Pramipexole
MDedge Internal Medicine
Heart Failure Hospitalization, Deaths Decline with Depression Intervention
MDedge Internal Medicine
Smoking Relapse Deadly for Stroke Survivors
MDedge Internal Medicine
Severe Psoriasis Linked to Doubled Diabetes Risk
MDedge Internal Medicine
ACCESS-EU Registry Confirms MitraClip Benefits in HF
MDedge Internal Medicine
CRT's Mild Heart Failure Benefits Persist 5 Years
MDedge Internal Medicine
Agent Shunts Fluid Overload Via GI Tract
MDedge Internal Medicine
Spironolactone's Heart Failure Benefit Outweighs Hyperkalemia Risk
MDedge Internal Medicine